ATE238310T1 - Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung - Google Patents

Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung

Info

Publication number
ATE238310T1
ATE238310T1 AT97940434T AT97940434T ATE238310T1 AT E238310 T1 ATE238310 T1 AT E238310T1 AT 97940434 T AT97940434 T AT 97940434T AT 97940434 T AT97940434 T AT 97940434T AT E238310 T1 ATE238310 T1 AT E238310T1
Authority
AT
Austria
Prior art keywords
cefditors
pivoxil
production
crystalline substance
crystalline
Prior art date
Application number
AT97940434T
Other languages
English (en)
Inventor
Kiyoshi Yasui
Masahiro Onodera
Masamichi Sukegawa
Tatsuo Watanabe
Yuichi Yamamoto
Yasushi Murai
Katsuharu Iinuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE238310T1 publication Critical patent/ATE238310T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97940434T 1996-09-20 1997-09-19 Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung ATE238310T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24956196 1996-09-20
PCT/JP1997/003340 WO1998012200A1 (en) 1996-09-20 1997-09-19 A crystalline substance of cefditoren pivoxyl and the production of the same

Publications (1)

Publication Number Publication Date
ATE238310T1 true ATE238310T1 (de) 2003-05-15

Family

ID=17194838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97940434T ATE238310T1 (de) 1996-09-20 1997-09-19 Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung

Country Status (25)

Country Link
US (2) US6294669B1 (de)
EP (1) EP0937083B1 (de)
JP (1) JP3403206B2 (de)
KR (1) KR100441907B1 (de)
CN (1) CN1116299C (de)
AR (1) AR008483A1 (de)
AT (1) ATE238310T1 (de)
AU (1) AU714735B2 (de)
BR (1) BR9712072A (de)
CA (1) CA2265686C (de)
CZ (1) CZ295199B6 (de)
DE (1) DE69721290T2 (de)
EA (1) EA001526B1 (de)
ES (1) ES2198593T3 (de)
HU (1) HU224196B1 (de)
ID (1) ID22064A (de)
IL (1) IL129016A (de)
NZ (1) NZ334883A (de)
PL (1) PL189548B1 (de)
PT (1) PT937083E (de)
RO (1) RO120196B1 (de)
SK (1) SK284973B6 (de)
TR (1) TR199900614T2 (de)
UA (1) UA55426C2 (de)
WO (1) WO1998012200A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9712072A (pt) * 1996-09-20 1999-08-24 Meiji Seika Kaisha Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma
EP1051978B1 (de) 1998-01-07 2012-08-22 Meiji Seika Pharma Co., Ltd. Kristallographisch stabile amorphe cephalosporin zusammensetzungen und verfahren zu ihrer herstellung
ECSP003699A (es) * 1999-10-08 2002-04-23 Smithkline Beecham Corp Inhibidores de fab i
HU226640B1 (en) * 1999-10-18 2009-05-28 Egis Gyogyszergyar Nyilvanosan Process for producing amorphous atorvastatin calcium salt
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
DE60336149D1 (de) * 2002-08-16 2011-04-07 Immunogen Inc Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
EP1555024B1 (de) * 2002-10-02 2010-09-29 Meiji Seika Kaisha Ltd. Antibakterielle medizinische zusammensetzung mit erhöhtem oralem absorptionsvermögen
US7244842B2 (en) * 2002-11-15 2007-07-17 Orchid Chemicals & Pharmaceuticals Ltd. Amorphous hydrate of a cephalosporin antibiotic
EP1575951B1 (de) 2002-12-06 2014-06-25 Debiopharm International SA Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
PL1606293T3 (pl) * 2003-03-27 2010-01-29 Basilea Pharmaceutica Ag Cefalosporyna w postaci krystalicznej
US8088387B2 (en) * 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
EP1660505A2 (de) * 2003-08-14 2006-05-31 Ranbaxy Laboratories Limited Verfahren zur selektiven herstellung des z-isomers von cefditoren und dessen pharmazeutisch unbedenklichen salzen und estern
KR101178657B1 (ko) * 2003-10-08 2012-08-30 메이지 세이카 파루마 가부시키가이샤 세프디토렌 피복실을 함유하는 비결정질 항균 조성물
WO2005044824A2 (en) * 2003-11-07 2005-05-19 Ranbaxy Laboratories Limited Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin
JP2005162696A (ja) * 2003-12-04 2005-06-23 Nichiko Pharmaceutical Co Ltd 溶出性に優れたセフジトレンピボキシル製剤
US8450307B2 (en) 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
WO2006024900A1 (en) * 2004-08-31 2006-03-09 Ranbaxy Laboratories Limited Highly pure cefditoren pivoxil
CA2632476A1 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
US20080069879A1 (en) * 2006-05-02 2008-03-20 Ravishekhar Bhiwgade Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof
EP2687533B1 (de) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamidderivate als FAB-I-Hemmer
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
EP2520578A1 (de) 2011-05-06 2012-11-07 Lupin Limited Verfahren zur Reinigung von Cephalosporinen
CN103421025B (zh) * 2012-05-21 2016-05-11 上海医药工业研究院 制备7α-甲氧基头孢菌素C的方法
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
KR101561963B1 (ko) * 2013-05-23 2015-10-22 영진약품공업 주식회사 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법
CN103665002B (zh) * 2013-12-18 2016-02-03 成都医路康医学技术服务有限公司 一种头孢妥仑匹酯的制备方法
WO2016114727A1 (en) 2015-01-16 2016-07-21 Öğün Yusuf Toktamiş Cefditoren pivoxil compositions with improved stability and production methods thereof
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
MY203711A (en) 2019-02-14 2024-07-15 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja) 2019-06-14 2024-01-19 デバイオファーム インターナショナル エス．エー． バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
EP0723965B1 (de) * 1993-09-29 2001-05-30 Meiji Seika Kaisha Ltd. Neue cephalosporinderivate
PT658558E (pt) * 1993-11-17 2001-06-29 Biochemie Gmbh Separacao de isomeros da cefalosporina
BR9712072A (pt) * 1996-09-20 1999-08-24 Meiji Seika Kaisha Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma

Also Published As

Publication number Publication date
PL332314A1 (en) 1999-08-30
HUP9903454A3 (en) 2001-04-28
SK284973B6 (sk) 2006-03-02
SK35499A3 (en) 2000-03-13
JP3403206B2 (ja) 2003-05-06
CN1116299C (zh) 2003-07-30
CN1234036A (zh) 1999-11-03
ID22064A (id) 1999-08-26
UA55426C2 (uk) 2003-04-15
CA2265686C (en) 2006-10-31
AU4222297A (en) 1998-04-14
EP0937083B1 (de) 2003-04-23
AR008483A1 (es) 2000-01-19
WO1998012200A1 (en) 1998-03-26
NZ334883A (en) 2000-09-29
BR9712072A (pt) 1999-08-24
PT937083E (pt) 2003-08-29
US6441162B2 (en) 2002-08-27
JP2001500521A (ja) 2001-01-16
CZ97599A3 (cs) 1999-08-11
HUP9903454A2 (hu) 2000-03-28
CA2265686A1 (en) 1998-03-26
HK1022912A1 (en) 2000-08-25
KR100441907B1 (ko) 2004-07-27
KR20000048496A (ko) 2000-07-25
ES2198593T3 (es) 2004-02-01
CZ295199B6 (cs) 2005-06-15
EP0937083A1 (de) 1999-08-25
DE69721290D1 (de) 2003-05-28
HU224196B1 (hu) 2005-06-28
IL129016A (en) 2003-01-12
AU714735B2 (en) 2000-01-13
US6294669B1 (en) 2001-09-25
RO120196B1 (ro) 2005-10-28
EA199900311A1 (ru) 1999-10-28
DE69721290T2 (de) 2004-01-22
US20020002279A1 (en) 2002-01-03
IL129016A0 (en) 2000-02-17
TR199900614T2 (xx) 1999-06-21
PL189548B1 (pl) 2005-08-31
EA001526B1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
ATE238310T1 (de) Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung
DE69504892D1 (de) Mischelement und Verfahren zu dessen Herstellung
DE69636166D1 (de) Klebstoffzusammensetzung und verfahren zu ihrer herstellung
DE69331176D1 (de) Knochenzement und Verfahren zu seiner Herstellung
DE69733416D1 (de) Erythromycine und verfahren zu ihrer herstellung
DE69532895D1 (de) Biomaterial und verfahren zu dessen herstellung
DE69518830D1 (de) Polypropylenreaktionsmischung und verfahren zu ihrer herstellung
DE69720523D1 (de) Polyolefin-polyethylenoxid-mischungen und verfahren zu deren herstellung
DE69409907D1 (de) Hochmicroporöse Kohlenstoffe und Verfahren zu ihrer Herstellung
DE69611599D1 (de) Halbaromatische polyamidzusamensetzung und verfahren zu ihrer herstellung
DE69616516D1 (de) Wasserschutzzusammensetzungen und verfahren zu deren herstellung
DE69620405D1 (de) Verbesserte polyarylenetherzusammensetzungen und verfahren zu ihrer herstellung
DE69703993D1 (de) Einbügelbarer Einlagestoff und Verfahren zu dessen Herstellung
ATE220666T1 (de) 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
ATE231840T1 (de) Pyrrolidinylhydroxamsäuren und verfahren zu ihrer herstellung
DE69433296D1 (de) Eisen-lactoferrin kombination und verfahren zu ihrer herstellung
DE69510774D1 (de) Katschukzusammensetzung und verfahren zu ihrer herstellung
DE69801795D1 (de) Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung
ATA75297A (de) Dekorlaminat und verfahren zu seiner herstellung
DE69738570D1 (de) Konzentrierte wässerige tensidzusammensetzungen von betaintyp und verfahren zu deren herstellung
DE69528271D1 (de) Flüssigkristalline copolyesterimide und verfahren zu ihrer herstellung
DE69523571D1 (de) Pyridylimidazol-derivate und verfahren zu ihrer herstellung
DE69527445D1 (de) Aminooligosaccharid-derivate und verfahren zu ihrer herstellung
DE69628754D1 (de) Leicht absorbierbares kalzium enthaltende zusammensetzung und verfahren zu ihrer herstellung
DE69735099D1 (de) Antibiotika rk-1061 und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0937083

Country of ref document: EP

EEFA Change of the company name